Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
10.54
+0.79 (8.10%)
At close: Jun 18, 2026, 4:00 PM EDT
10.63
+0.09 (0.85%)
After-hours: Jun 18, 2026, 7:22 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $1.1 billion as of June 18, 2026. Its market cap has increased by 142.65% in one year.
Market Cap
1.10B
Enterprise Value
909.32M
1-Year Change
142.65%
Ranking
Category
Stock Price
$10.54
Market Cap Chart
Since June 20, 2019, Personalis's market cap has increased from $847.61M to $1.10B, an increase of 30.22%. That is a compound annual growth rate of 3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.10B | 56.14% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 4.09B |
| Adaptive Biotechnologies | 2.69B |
| GRAIL | 2.55B |
| GeneDx Holdings | 1.67B |
| NeoGenomics | 1.35B |
| CareDx | 1.21B |
| OPKO Health | 1.06B |
| Castle Biosciences | 614.48M |